Aurora Cannabis Inc (NASDAQ:ACB) — Market Cap & Net Worth
Market Cap & Net Worth: Aurora Cannabis Inc (ACB)
Aurora Cannabis Inc (NASDAQ:ACB) has a market capitalization of $172.06 Million ($172.06 Million) as of August 7, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17143 globally and #4010 in its home market, demonstrating a 6.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aurora Cannabis Inc's stock price $2.91 by its total outstanding shares 59126604 (59.13 Million). See Aurora Cannabis Inc (ACB) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Aurora Cannabis Inc Market Cap History: 2015 to 2026
Aurora Cannabis Inc's market capitalization history from 2015 to 2026. Data shows change from $2.94 Billion to $172.06 Million (-20.54% CAGR).
Index Memberships
Aurora Cannabis Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.48 Trillion | 0.01% | #474 of 976 |
|
NASDAQ Composite
IXIC
|
$40.85 Trillion | 0.00% | #1683 of 3165 |
Weight: Aurora Cannabis Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aurora Cannabis Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aurora Cannabis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.73x
Aurora Cannabis Inc's market cap is 0.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
156.83x
Aurora Cannabis Inc's market cap is 156.83 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $12.07 Billion | $1.44 Million | -$5.72 Million | 8385.88x | N/A |
| 2017 | $53.53 Billion | $18.07 Million | -$12.97 Million | 2962.92x | N/A |
| 2018 | $35.19 Billion | $55.20 Million | $71.94 Million | 637.59x | 489.21x |
| 2019 | $15.33 Billion | $245.54 Million | -$293.51 Million | 62.42x | N/A |
| 2020 | $4.91 Billion | $268.70 Million | -$3.28 Billion | 18.29x | N/A |
| 2021 | $3.20 Billion | $245.25 Million | -$693.62 Million | 13.04x | N/A |
| 2022 | $545.50 Million | $221.34 Million | -$1.72 Billion | 2.46x | N/A |
| 2023 | $281.56 Million | $223.80 Million | -$816.63 Million | 1.26x | N/A |
| 2024 | $251.29 Million | $270.28 Million | -$69.33 Million | 0.93x | N/A |
| 2025 | $249.51 Million | $343.29 Million | $1.59 Million | 0.73x | 156.83x |
Competitor Companies of ACB by Market Capitalization
Companies near Aurora Cannabis Inc in the global market cap rankings as of August 7, 2026.
Key companies related to Aurora Cannabis Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #541 globally with a market cap of $49.98 Billion USD ( CN¥341.53 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #551 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #625 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #541 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.98 Billion | CN¥53.54 |
| #551 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $44.04 |
| #625 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.20 |
Aurora Cannabis Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Aurora Cannabis Inc's market cap moved from $2.94 Billion to $ 172.06 Million, with a yearly change of -20.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $172.06 Million | -31.04% |
| 2025 | $249.51 Million | -0.71% |
| 2024 | $251.29 Million | -10.75% |
| 2023 | $281.56 Million | -48.38% |
| 2022 | $545.50 Million | -82.95% |
| 2021 | $3.20 Billion | -34.90% |
| 2020 | $4.91 Billion | -67.94% |
| 2019 | $15.33 Billion | -56.45% |
| 2018 | $35.19 Billion | -34.26% |
| 2017 | $53.53 Billion | +343.60% |
| 2016 | $12.07 Billion | +310.11% |
| 2015 | $2.94 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Aurora Cannabis Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $172.06 Million USD |
| MoneyControl | $172.06 Million USD |
| MarketWatch | $172.06 Million USD |
| marketcap.company | $172.06 Million USD |
| Reuters | $172.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more